Furthermore, Smo negatively correlated with serum AST, NASH activity score, and hepatocyte ballooning scores (Figure 11B–D), linking Smo loss to increased severity of lipotoxic liver injury. This evidence concerns the gene GOT1 and metabolic dysfunction-associated steatohepatitis.